BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.09B |
| 2 |
Tesla
TSLA
|
+$488M |
| 3 |
AbbVie
ABBV
|
+$312M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$271M |
| 5 |
Abbott
ABT
|
+$253M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
+$642M |
| 2 |
Apple
AAPL
|
+$610M |
| 3 |
Visa
V
|
+$487M |
| 4 |
iShares MSCI ACWI ETF
ACWI
|
+$441M |
| 5 |
Technology Select Sector SPDR Fund
XLK
|
+$252M |
Sector Composition
| 1 | Technology | 18.06% |
| 2 | Financials | 12.01% |
| 3 | Consumer Discretionary | 9.98% |
| 4 | Healthcare | 8.94% |
| 5 | Communication Services | 6.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RVNC
2101
DELISTED
Revance Therapeutics, Inc.
RVNC
| $259K | ﹤0.01% |
8,725
-10,254
| -54% | -$304K |
|
2102
Cross Country Healthcare
CCRN
$411M
| $257K | ﹤0.01% |
15,582
-1,582
| -9% | -$26.1K |
|
2103
Sanofi
SNY
$115B
| $256K | ﹤0.01% |
4,858
+3,070
| +172% | +$162K |
|
|
ZUO
2104
DELISTED
Zuora, Inc.
ZUO
| $255K | ﹤0.01% |
14,806
-16,512
| -53% | -$285K |
|
2105
PDF Solutions
PDFS
$765M
| $250K | ﹤0.01% |
13,761
+7,858
| +133% | +$143K |
|
|
HEP
2106
DELISTED
Holly Energy Partners, L.P.
HEP
| $249K | ﹤0.01% |
10,992
+39
| +0.4% | +$883 |
|
2107
WisdomTree
WT
$2.11B
| $249K | ﹤0.01% |
40,109
-29,088
| -42% | -$180K |
|
2108
Brown-Forman Class A
BF.A
$13.2B
| $248K | ﹤0.01% |
3,523
-421
| -11% | -$29.7K |
|
2109
CBIZ
CBZ
$3.01B
| $248K | ﹤0.01% |
7,579
-12,608
| -62% | -$413K |
|
2110
Vuzix
VUZI
$172M
| $247K | ﹤0.01% |
+13,452
| New | +$247K |
|
2111
Yext
YEXT
$1.07B
| $245K | ﹤0.01% |
17,138
-11,540
| -40% | -$165K |
|
2112
Brookfield Renewable
BEP
$7.19B
| $244K | ﹤0.01% |
6,331
-5,119
| -45% | -$197K |
|
2113
Marcus Corp
MCS
$504M
| $244K | ﹤0.01% |
11,497
-242
| -2% | -$5.13K |
|
|
KRTX
2114
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $243K | ﹤0.01% |
2,134
+144
| +7% | +$16.4K |
|
2115
BCE
BCE
$22.5B
| $242K | ﹤0.01% |
4,900
| – | – |
|
2116
First Interstate BancSystem
FIBK
$3.43B
| $239K | ﹤0.01% |
5,722
-12,259
| -68% | -$513K |
|
2117
Akebia Therapeutics
AKBA
$782M
| $239K | ﹤0.01% |
63,068
-11,500
| -15% | -$43.6K |
|
2118
Workhorse Group
WKHS
$17.7M
| $238K | ﹤0.01% |
57
-124
| -69% | -$518K |
|
|
SWAV
2119
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $238K | ﹤0.01% |
1,253
-2,465
| -66% | -$468K |
|
2120
Axsome Therapeutics
AXSM
$5.91B
| $238K | ﹤0.01% |
3,524
-2,762
| -44% | -$186K |
|
|
RDFN
2121
DELISTED
Redfin
RDFN
| $238K | ﹤0.01% |
3,747
-9,989
| -73% | -$633K |
|
2122
Liquidity Services
LQDT
$849M
| $237K | ﹤0.01% |
9,322
-3,770
| -29% | -$95.9K |
|
2123
Global X Cloud Computing ETF
CLOU
$309M
| $236K | ﹤0.01% |
8,262
-20,666
| -71% | -$590K |
|
2124
Clearwater Paper
CLW
$344M
| $236K | ﹤0.01% |
8,138
-1,020
| -11% | -$29.5K |
|
2125
Kornit Digital
KRNT
$647M
| $235K | ﹤0.01% |
1,893
-936
| -33% | -$116K |
|